apoB,apoA1及apoB/apoA1比值在冠心病患病风险及预后评估中的应用进展

被引：8

作者：

朱梅

王士雯

机构：

[1] 北京市海淀区解放军总医院老年心血管病研究所

来源：

中国实用医药 | 2009年 / 4卷 / 12期

关键词：

apoB; apoA1; 冠心病; 危险因素;

D O I：

10.14163/j.cnki.11-5547/r.2009.12.087

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

摘要：

引用

页码：228 / 230

页数：3

共 8 条

[1]

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries （the INTERHEART study）: a case-control study[J] . Matthew J McQueen,Steven Hawken,Xingyu Wang,Stephanie Ounpuu,Allan Sniderman,Jeffrey Probstfield,Krisela Steyn,John E Sanderson,Mohammad Hasani,Emilia Volkova,Khawar Kazmi,Salim Yusuf.The Lancet . 2008 (9634)

[2] Childhood levels of serum Apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood [J].

Juonala, Markus ;

Viikari, Jorma S. A. ;

Kahonen, Mika ;

Solakivi, Tiina ;

Helenius, Hans ;

Jula, Antti ;

Marniemi, Jukka ;

Taittonen, Leena ;

Laitinen, Tomi ;

Nikkari, Tapio ;

Raitakari, Olli T. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (04) :293-299

[3]

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment[J] . John J.P. Kastelein,Wim A. van der Steeg,Ingar Holme,Michael Gaffney,Nilo B. Cater,Philip Barter,Prakash Deedwania,Anders G. Olsson,S Matthijs Boekholdt,David A. Demicco,Michael Szarek,John C. LaRosa,Terje R. Pedersen,Scott M. Grundy.Circulation . 2008 (23)

[4]

Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study[J] . G. Bruno,F. Merletti,A. Biggeri,G. Bargero,S. Prina-Cerai,G. Pagano,P. Cavallo-Perin.Diabetologia . 2006 (5)

[5]

Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men[J] . Tobias Pischon,Cynthia J. Girman,Frank M. Sacks,Nader Rifai,Meir J. Stampfer,Eric B. Rimm.Circulation . 2005 (22)

[6]

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk[J] . G?ran Walldius,Ingmar Jungner,Are H. Aastveit,Ingar Holme,Curt D. Furberg,Allan D. Sniderman.Clinical Chemical Laboratory Medicine . 2004 (12)

[7] Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS) [J].